Admission Date:  [**2145-12-15**]              Discharge Date:   [**2145-12-28**]  Date of Birth:  [**2084-8-9**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 5552**] Chief Complaint: from ED for sepsis  Major Surgical or Invasive Procedure: placement of biliary drains   History of Present Illness: The pt.
He is s/p Whipple and gemcitabine treatment for pancreatice cancer.
Dr. [**First Name (STitle) **] [**Name (STitle) **] attempted to place a stent by ERCP on [**11-17**].
The paitent was placed on levaquin and he proceeded on his trip to [**Country 11150**].
He then he underwent a percutaneous biliary drain placement on [**12-10**].
He was monitored in house for 2 days while the drain was draining.
Yesterday, he called Dr. [**Last Name (STitle) **] saying he had a fever and he was restarted on Levaquin.
He was recusistated with 7 L NS and BP improved.
He recieved Unasyn, ibuprofen, tylenol, vancomycin and oxycodone for pain at the drain site.
Drain was uncapped.
In [**2142**], he underwent a resection and Whipple by Dr. [**Last Name (STitle) 468**].
he then underwent a right VATS for lund nodules which showed pancreatic adneocarcinoma.
He was initially treated with infusional Gemcitabine and responded well.
He received his last dose of infusional Gemcitabine on [**11-18**],[**2143**].
He received no treatment since infusional Gemcitabine until his CAT scan showed new multiple hepatic metastases.
He was being treated on the Xelox protocol but developed severe diarrhea (grade 2), hand foot syndrome (grade 2) and dehydration.
He then expressed the wish to discontinue treatment at this time.
drain site with dressing soaked.
Micro: [**12-15**] and [**12-16**] Bld cx and bile - grew E. coli                               SENSITIVITIES: MIC expressed in MCG/ML                              ESCHERICHIA COLI                              | AMPICILLIN------------  =>32 R AMPICILLIN/SULBACTAM--    16 I CEFAZOLIN-------------   <=4 S CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CEFUROXIME------------    16 I CIPROFLOXACIN---------   =>4 R GENTAMICIN------------     8 I IMIPENEM--------------   <=1 S LEVOFLOXACIN----------   =>8 R MEROPENEM-------------<=0.25 S PIPERACILLIN----------    32 I PIPERACILLIN/TAZO-----   <=4 S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S .
Status post Whipple surgery.
Non-specific stranding in the right upper quadrant.
[**12-20**] Cholangiogram  Nondilated right-sided biliary ducts were opacified.
A new 8-French internal/external biliary drainage catheter was advanced over the wire and connected to a bag for drainage.
The catheter was secured with 0-Proelene sutures and a dressing was applied.
male with metastatic pancreatic cancer s/p percutaneous biliary drain placement who returned with septic shock.
He was aggressively hydrated and started on zosyn IV and vancomycin.
His blood cultures and biliary fluid subsequently grew e. coli and the vancomycin was discontinued.
IR was reconsulted, the cholangiogram showed obstruction of the left sided bile duct and a second biliary drain was placed to improve drainage.
He received a total of 4 units of PRBCs during this hospitalization to maintain a hct>27.
# Coagulopathy: Patient was coagulopathic on admission and received a dose of vitamin K after which his coagulopathy resolved.
Patient was started on oxycontin [**Hospital1 **] with oxycodone PRN.
# Thrombocytopenia: Patient had thrombocytopenia initially which resolved without intervention and was attributed to sepsis/consumption.
# h/o HTN: Lisinopril was held due to hypotension # Hyperlipidemia: Held lipitor in setting of liver dysfunction   Medications on Admission: 1. protonix 2. compazine 3. celexa 4. lisinopril 5.
Insulin  Discharge Medications: 1.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Amylase-Lipase-Protease 33,200-10,000- 37,500 unit Capsule, Delayed Release(E.C.)
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed for pain.
Oxycodone 10 mg Tablet Sustained Release 12HR Sig: One (1) Tablet Sustained Release 12HR PO Q12H (every 12 hours).
Disp:*60 Tablet Sustained Release 12HR(s)* Refills:*0* 8.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Phenazopyridine 100 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) for 2 days.
Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical  QD (): patch should be put on for 12 hours, then off for 12 hours each day.
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 5 days.
Insulin Regular Human 100 unit/mL Solution Sig: as directed Injection ASDIR (AS DIRECTED): Please continue your usual home regimen of insulin.
Ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for pain.
Discharge Disposition: Home With Service  Facility: [**Company 1519**]  Discharge Diagnosis: Primary Diagnoses: Pancreatic cancer with hepatic and pulmonary metastases E. coli bacteremia and sepsis hyponatremia, likely due to SIADH thrombocytopenia, likely due to sepsis Secondary Diagnoses: diabetes, secondary to pancreatic cancer pancreatic insufficiency hyperlipidemia   Discharge Condition: stable   Discharge Instructions: If you experience worsening fevers, chills, abdominal pain, or other concerning symptoms, please call your doctor or return to the emergency room for evaluation.
Please take all medications as prescribed.
Please talk to your doctor about whether these medications should be restarted.
You should also contact Interventional Radiology to have your drains evaluated and/or changed.
